Treating Chronic Pain in Buprenorphine Patients in Primary Care Settings

NACompletedINTERVENTIONAL
Enrollment

163

Participants

Timeline

Start Date

August 21, 2019

Primary Completion Date

June 28, 2024

Study Completion Date

December 20, 2024

Conditions
Opioid-Related Disorders
Interventions
BEHAVIORAL

Treating Opioid Patients' Pain and Sadness (TOPPS)

TOPPS, consists of three main components: (1) psychoeducation about pain, depression, opioid use, their interactions, and the maintaining role of avoidance; (2) coaching in being an informed, activated patient (based in part on the chronic care model and on approaches to self-management of chronic illness); and (3) behavioral activation to increase engagement in meaningful activities.

BEHAVIORAL

Health Education (HE)

Participants randomized to the control HE condition are offered six telephone sessions led by the Behavioral Health Specialists. The first health session is around nutrition. At the remaining sessions, participants choose from a menu of topics, including: a second session on nutrition; germs, colds and the flu; preventing cancer; diabetes; protecting your heart; getting a good night's sleep; complementary and alternative medicine; caffeine, or physical activity.

Trial Locations (2)

02118

Boston Medical Center, Boston

02720

Stanley Street Treatment and Resources, Fall River

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Boston University

OTHER

NCT03698669 - Treating Chronic Pain in Buprenorphine Patients in Primary Care Settings | Biotech Hunter | Biotech Hunter